Melanoma Trial, Recruiting NCT05373823 Sponsor: Rutgers, The State University of New Jersey Condition: Melanoma
Back to Melanoma

Melanoma Trial, Recruiting

NCT05373823
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with primary skin melanoma (a type of skin cancer) at stages 0 through III
  • People who had surgery between three months and five years ago to treat their melanoma
  • People who currently show no signs of cancer
  • People who have not been doing regular full-body skin checks (meaning they have not checked their entire body for skin changes at least once in the past three months)
  • People who are 18 years of age or older
  • People who have access to the internet
  • People who can speak and read English
  • People who are able to give informed consent (meaning they can understand and agree to participate in the study)

Who may not be able to join:

  • Children (people under 18 years of age)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sharon Manne, PhD, Rutgers Cancer Institute of New Jersey

Phone: 732-235-6759

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rutgers, The State University of New Jersey
Registry
ClinicalTrials.gov
Start date
6 March 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Body parts examined; Body parts examined; Body parts examined; Body parts examined; Body parts examined

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov